Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 19

    FDA approves first drug to treat tardive dyskinesia

    FDA approves first drug to treat tardive dyskinesia

    supriya kashyap kashyap12 April 2017 12:09 PM IST
    The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug...
    FDA allows marketing of first direct-to-consumer Gene Test

    FDA allows marketing of first direct-to-consumer Gene Test

    supriya kashyap kashyap10 April 2017 11:35 AM IST
    The US Food and Drug Administration allowed marketing of 23 and Me Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or...
    Torrent soon to buy womens healthcare portfolio from Novartis

    Torrent soon to buy women's healthcare portfolio from Novartis

    supriya kashyap kashyap10 April 2017 11:32 AM IST
    Mumbai : Ahmedabad-based drug maker Torrent Pharmaceuticals is very close to finalise a deal for acquiring women's healthcare portfolio from Swiss...
    FDA approves two hepatitis C drugs for pediatric patients

    FDA approves two hepatitis C drugs for pediatric patients

    supriya kashyap kashyap8 April 2017 12:05 PM IST
    The U.S. Food and Drug Administration approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat...
    Practo unveils its new brand identity

    Practo unveils its new brand identity

    supriya kashyap kashyap7 April 2017 9:25 AM IST
    Bengaluru : Practo, the leading healthcare platform, unveiled its new brand identity and positioning Your Home for Health. Practo’s platform is...
    MED-EL announces expansion in India to restore hearing abilities among deaf

    MED-EL announces expansion in India to restore hearing abilities among deaf

    supriya kashyap kashyap3 April 2017 11:33 AM IST
    New Delhi : MED-EL India, the Indian subsidiary of the global leading provider of hearing implant systems MED-EL, known for developing innovative...
    Drugs being developed under the AYUSH system of medicine, Check out details

    Drugs being developed under the AYUSH system of medicine, Check out details

    supriya kashyap kashyap3 April 2017 11:32 AM IST
    Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central...
    FDA approves Qudexy XR for migraine prophylaxis in adults, adolescents

    FDA approves Qudexy XR for migraine prophylaxis in adults, adolescents

    supriya kashyap kashyap3 April 2017 11:31 AM IST
    The FDA has approved two supplemental new drug applications for Qudexy XR extended-release capsules, a once-daily prophylactic medication for migraine...
    FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

    FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

    supriya kashyap kashyap2 April 2017 11:49 AM IST
    The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen...
    FDA approves new drug to treat multiple sclerosis

    FDA approves new drug to treat multiple sclerosis

    supriya kashyap kashyap2 April 2017 11:46 AM IST
    The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and...
    Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine

    Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine

    supriya kashyap kashyap2 April 2017 11:31 AM IST
    New Delhi : Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, signed a Memorandum of Understanding (MoU) with...
    Lupin launches Generic Epzicom tablets in the US

    Lupin launches Generic Epzicom tablets in the US

    supriya kashyap kashyap31 March 2017 2:50 PM IST
    Mumbai : Pharma Major Lupin Limited (Lupin) announced the launch of Abacavir and Lamivudine tablets, 600 mg/300 mg having received an approval from...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Government appoints 108 drug inspectors pan India; Details

    Government appoints 108 drug inspectors pan India; Details

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok